Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29.5M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
36.4M
-
Shares change
-
+27.9M
-
Total reported value, excl. options
-
$143M
-
Value change
-
+$112M
-
Put/Call ratio
-
0.02
-
Number of buys
-
37
-
Number of sells
-
-20
-
Price
-
$3.94
Significant Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q2 2018
69 filings reported holding MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value as of Q2 2018.
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.4M shares
.
Largest 10 shareholders include Vivo Capital, LLC (6.6M shares), NEA Management Company, LLC (5.72M shares), CAXTON CORP (4.4M shares), BVF INC/IL (3.08M shares), BOXER CAPITAL, LLC (2.91M shares), RENAISSANCE TECHNOLOGIES LLC (2.22M shares), Sio Capital Management, LLC (2.18M shares), MILLENNIUM MANAGEMENT LLC (1.39M shares), VANGUARD GROUP INC (1.38M shares), and ACUTA CAPITAL PARTNERS, LLC (880K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.